CORAL GABLES, FL / ACCESSWIRE / January 16, 2019 / The healthcare industry is predicated on the notion that as diseases become more advanced and difficult to treat, companies responsible for creating treatment options will rise to the occasion to assist patients suffering from said ailments. Given that the world's population is consistently increasing, and resources are diminishing, access to healthcare is something crucial to the health and wellness of every living person, presenting a dire need for companies on a global scale. As healthcare companies work to develop new methods for bettering the care provided to their patients, the industry, in its entirety, will unite to meet the demands and needs of consumers in the space looking for qualitative healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Microbot Medical Inc (MBOT), Kitov Pharma Ltd (KTOV), and Teladoc Health Inc (TDOC) are 4 healthcare stocks representing companies invested in creating the best quality treatments for their patients.
Premier Health Group (OTC:PHGRF) (CSE:PHGI) saw impressive gains in the month of December, as the Company's shares hit highs of 0.80 to mark a move of more than 30% over the course of the 30-day period. As the cannabis sector has garnered notoriety and seen a significant increase in public support, Premier has focused its efforts on investing in opportunities that combine healthcare and cannabis. The Company announced, back in November, that it had engaged discussions with licensed producers under the Access to Cannabis for Medical Purposes Regulation, other licensed medical cannabis companies, and government officials in order to establish a primordial framework for both patient and physician education surrounding medical cannabis.
In recent news, Premier Health Group (OTC:PHGRF) (CSE:PHGI) announced that, further to its news release dated December 17, 2018, the Company has signed a Definitive Agreement to acquire all of the outstanding securities of Cloud Practice Inc. Per the announcement, Cloud Practice's founders, including CEO Jordan Visco, and the entire support team, will join and work alongside the Premier Health team.
''We are very excited to have completed this acquisition and to have the experienced team at Cloud Practice join the team at Premier Health. With this acquisition, we now have a medical software company with national reach. Thus, enabling us to build on our patient centric technology platform that will integrate telemedicine, online booking and other premium services with our electronic medical records (EMR) system,'' said Dr. Essam Hamza, CEO of Premier.
For More Information On Premier Health Group, Click Here
Microbot Medical Inc (MBOT) announced today that after a significant experimentation period, the Company has finally validated the effectiveness of its Self-Cleaning Shunt in a recent independent in-vitro laboratory study. The Company also shared images of its new technology that clearly demonstrate the device prevented shunt occlusion.
In a press release regarding the announcement Harel Gadot, CEO, President and Chairman of the Company, said, ''We believe the highly encouraging results from this latest study, which complements our previous pre-clinical studies, demonstrates the potential of our SCSTM product to revolutionize how Hydrocephalus and Normal Pressure Hydrocephalus (NPH) can be treated in the future. We believe the performance of the SCSTM during this and previous studies gives us greater confidence to explore additional medical applications for the device in conditions where occlusion occurs, such as in the Traumatic Brain Injury (TBI) space.''
For More Information On Microbot Medical, Inc., Click Here
Kitov Pharma Ltd (KTOV), an innovative pharmaceutical company, today announced new findings from its ongoing collaborative efforts with researchers from Hebrew University in Jerusalem. The data reveal NT219's high affinity and selective binding to its target proteins.
In response to the announcement, Isaac Israel, Kitov's CEO, said, ''We are excited about the new data which demonstrate NT219's unique mechanism of action. NT219, a new and promising concept in cancer therapy, is designed to prevent, reverse, and delay resistance to anti-cancer drugs. We are developing NT219 as a drug to be used in combination with other therapies that has a potential to overcome cancer drug resistance and to boost the efficacy of numerous oncology drugs on the market today.''
For More Information on Kitov Pharma Ltd, Click Here
Teladoc Health Inc (TDOC), a global leader in the virtual care sub-sect of the greater healthcare industry, announced in mid-December, that, in an effort to maintain a cohesive leadership team consisting of members dedicated to the Company and its mission, Mark Hirschhorn had resigned as Executive Vice President, Chief Operating Officer, and Chief Financial Officer, effective January 1, 2019.
Following the announcement, Mr. Hirschhorn commented, ''While this was a difficult decision, it's the right one for my family and the company. It has been an enormous privilege to play a role in transforming how people access healthcare around the world, and I know the talented team at Teladoc Health is well positioned to continue advancing this important mission.''
For More Information On Teladoc Health, Inc., Click Here
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 - 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid ''500,000'' shares of restricted common shares (as of 1/16/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the ''500,000'' shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer.
SOURCE: Stock Price